HCPCS Q0243 — Casirivimab and imdevimab (2026 RVU Values)

HCPCS code Q0243 (Casirivimab and imdevimab) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.

Related references